Gangloff Scott A. - Insider Non-Derivative Transactions at Akero Therapeutics, Inc. (AKRO) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 9, 2025, Gangloff Scott A.'s relationship to Akero Therapeutics, Inc. (AKRO) is Officer (Chief Technology Officer), and currently has 0 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other AKRO insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Gangloff Scott A. - Insider Non-Derivative Transactions of AKRO Common Stock

Gangloff Scott A. - Insider Non-Derivative Transactions at AKRO

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 10, 2025	Disposition -- (Common Stock)	21263	0	0
Dec 10, 2025	Disposition -- (Common Stock)	5088	0	0
Aug 16, 2025	M -- (Common Stock)	2600	19.62	26351
Jul 1, 2025	Acquisition -- (Common Stock)	299	23.87	23751
Jun 19, 2025	Sell -- (Common Stock)	848	54.84	23452
Dec 17, 2024	Acquisition -- (Common Stock)	24300	0	24300